| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/30/2011 | WO2011076734A1 Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases |
| 06/30/2011 | WO2011076721A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| 06/30/2011 | WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 06/30/2011 | WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics |
| 06/30/2011 | WO2010067010A3 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110160642 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| 06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 06/30/2011 | US20110160296 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160283 Modulation of cd40 expression |
| 06/30/2011 | US20110160281 RNA Interference Mediated Inhibition of Vascular Cell Adhesion Molecule (VCAM) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 06/30/2011 | US20110160271 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 06/30/2011 | US20110160244 Phenylpiperidine modulators of mu-opioid receptor |
| 06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 06/30/2011 | US20110160240 Polymorphs and salts of a kinase inhibitor |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
| 06/30/2011 | US20110160220 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160213 Pharmaceutical compositions for the treatment of inflammatory and allergic disorders |
| 06/30/2011 | US20110160208 Diaryl-substituted five-membered heterocycle derivative |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160195 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 06/30/2011 | US20110160187 3-aryl-5,6-disubstituted pyridazines |
| 06/30/2011 | US20110160180 Cannabinoid Receptor Ligands |
| 06/30/2011 | US20110160172 Fluoroquinolone derivatives for ophthalmic applications |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160157 Methods of treating an inflammatory-related disease |
| 06/30/2011 | US20110160142 Alpha B-Crystallin as a therapy for inflammation |
| 06/30/2011 | US20110160133 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160118 Methods and compositions for treating oral and esophageal lesions |
| 06/30/2011 | US20110159116 Biocompatible materials for medical devices |
| 06/30/2011 | US20110159104 Microemulsion |
| 06/30/2011 | US20110159100 Formulations and methods for the controlled release of active drug substances |
| 06/30/2011 | US20110159090 Abuse resistant drugs, method of use and method of making |
| 06/30/2011 | US20110159089 Abuse resistant drugs, method of use and method of making |
| 06/30/2011 | US20110159083 Nanoparticles for protein drug delivery |
| 06/30/2011 | US20110159078 Volatile Anesthetic Compositions and Methods of Use |
| 06/30/2011 | US20110159076 Autodestructive Transdermal Therapeutic System |
| 06/30/2011 | US20110159046 Controlled release formulations exhibiting an ascending rate of release |
| 06/30/2011 | US20110159011 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof |
| 06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158982 COMPOSITIONS AND METHODS FOR INHIBITING MAdCAM |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | US20110158922 Skin Care Compositions and Method of Use Thereof |
| 06/30/2011 | US20110158909 Cationic Contrast Agents and Methods of Use Thereof |
| 06/30/2011 | CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | CA2785451A1 Molecule for treating an inflammatory disorder |
| 06/30/2011 | CA2785360A1 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | CA2785353A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | CA2784894A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors |
| 06/30/2011 | CA2784891A1 Prodrugs of [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2783616A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses |
| 06/30/2011 | CA2687713A1 Treatment of cancer, arthritis, inflammation and other diseases by drawing on skin the big dose of vitamin e in oil and covering by film |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2339013A1 Methods for producing modified glycoproteins |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338485A1 Substituted 1,3-dioxoisoindolines as medicine |
| 06/29/2011 | EP2338475A2 Treating canker sores with patches to speed healing and relieve pain |
| 06/29/2011 | EP2338448A2 Anti-inflammatory and antimicrobial uses for bioactive glass |
| 06/29/2011 | EP2041094B1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 06/29/2011 | EP1755606B2 Quinazolinone derivatives useful as vanilloid antagonists |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | CN201881930U Automobile seat cushion |
| 06/29/2011 | CN1904606B Angelice dehurica crude drug alcoholic extract effective component group fingerprint map and its establishing method and application |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112478A 5H-pyrr0l0 [2, 3-B] pyrazine derivatives for kinase modulation, and indications therefor |
| 06/29/2011 | CN102112462A Aminopropylidene derivative |
| 06/29/2011 | CN102112453A Novel potassium channel blockers and uses thereof |
| 06/29/2011 | CN102112451A Diazepan and piperazine derivatives modulators of chemokine receptors |
| 06/29/2011 | CN102112449A Phenyl or pyridinyl substituted indazoles derivatives |
| 06/29/2011 | CN102112446A Phenanthrenone compounds, compositions and methods |
| 06/29/2011 | CN102112148A Use of cell-permeable peptide inhibitors of jnk signal transduction pathway for treatment of chronic or non-chronic inflammatory digestive diseases |
| 06/29/2011 | CN102112136A Composition for inhibiting expression of target gene |
| 06/29/2011 | CN102112133A Pharmaceutical uses of lanosta-8, 24-dien-3-ols |
| 06/29/2011 | CN102112121A Methods, compositions, and kits for treating pain and pruritis |
| 06/29/2011 | CN102108346A Method for preparing lysozyme |
| 06/29/2011 | CN102108090A Dihydroiso-coumarin glucoside compounds and preparation method and application thereof |
| 06/29/2011 | CN102108075A Method for synthesizing novel derivatives from gibberellane GA3 and use thereof |
| 06/29/2011 | CN102107000A Application of cholecystokinin octapeptide in pharmacy |
| 06/29/2011 | CN102106988A Chinese medicine preparation with effects on expelling wind, dispelling cold and dampness, promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain |
| 06/29/2011 | CN102106965A Composition for treating acute injury of soft tissue and application thereof |
| 06/29/2011 | CN102106950A Quality control method in NuJin capsule extraction and concentration process |